Correlation Between Salesforce and NAYA Biosciences,

Can any of the company-specific risk be diversified away by investing in both Salesforce and NAYA Biosciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and NAYA Biosciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Salesforce and NAYA Biosciences,, you can compare the effects of market volatilities on Salesforce and NAYA Biosciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of NAYA Biosciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and NAYA Biosciences,.

Diversification Opportunities for Salesforce and NAYA Biosciences,

0.66

Correlation Coefficient

Salesforce  NAYA Biosciences,

Poor diversification

The 3 months correlation between Salesforce and NAYA is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and NAYA Biosciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAYA Biosciences, and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with NAYA Biosciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAYA Biosciences, has no effect on the direction of Salesforce i.e., Salesforce and NAYA Biosciences, go up and down completely randomly.

Pair Corralation between Salesforce and NAYA Biosciences,

Considering the 90-day investment horizon Salesforce is expected to generate 0.21 times more return on investment than NAYA Biosciences,. However, Salesforce is 4.77 times less risky than NAYA Biosciences,. It trades about -0.16 of its potential returns per unit of risk. NAYA Biosciences, is currently generating about -0.2 per unit of risk. If you would invest  33,574  in Salesforce on December 29, 2024 and sell it today you would lose (5,793) from holding Salesforce or give up 17.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Salesforce  vs.  NAYA Biosciences,

Salesforce

Risk-Adjusted Performance

Very Weak

Over the last 90 days Salesforce has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

NAYA Biosciences,

Risk-Adjusted Performance

Very Weak

Over the last 90 days NAYA Biosciences, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Salesforce and NAYA Biosciences,

The main advantage of trading using opposite Salesforce and NAYA Biosciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, NAYA Biosciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NAYA Biosciences, will offset losses from the drop in NAYA Biosciences,'s long position.

The idea behind Salesforce and NAYA Biosciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.